查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1534451

藥用玻璃包裝市場 - 全球規模、佔有率、趨勢分析、機會、預測，2019-2030

Pharmaceutical Glass Packaging Market - Global Size, Share, Trend Analysis, Opportunity and Forecast, 2019-2030, Segmented By Material; By Route of Administration; By Product; By Drug Type; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2030年全球藥用玻璃包裝市場規模將突破300億美元

全球藥用玻璃包裝市場正在蓬勃發展，生物製藥行業對玻璃包裝的需求由於其卓越的安全性、可靠性和相容性而迅速成長。

領先的策略諮詢和市場研究公司 BlueWeave Consulting 在最近的一項研究中估計，2023 年全球藥用玻璃包裝市場規模為 195.6 億美元。 BlueWeave預測，在2024-2030年預測期內，全球藥用玻璃包裝市場規模將以8.18%的複合年成長率擴大，到2030年將達到300.3億美元。藥用玻璃包裝市場是由非專利藥注射藥物的日益普及和生物製藥行業的巨大需求推動的。基於石灰石、堿灰、玻璃屑和沙子的藥用玻璃含有鋇和鋅等必需元素，以提高耐化學性和耐用性。這些特性對於滿足嚴格的製藥標準並確保藥品安全和包裝完整性至關重要。由於疾病盛行率的增加，業界的擴張進一步增加了對可靠玻璃包裝的需求。玻璃包裝可保護藥品免受物理和生物危害並延長保存期限。隨著該行業的持續成長和技術進步，預計在分析期間藥用玻璃包裝的需求將激增。

BlueWeave預計2023年全球藥用玻璃包裝市場規模為682萬噸。 BlueWeave預測，在2024-2030年的預測期內，全球藥用玻璃包裝市場規模將以8.42%的複合年成長率成長，到2030年將達到911萬噸。有效的玻璃回收在滿足永續藥品包裝解決方案不斷成長的需求方面發揮關鍵作用。廢品回收產業協會強調，再生玻璃可以取代新生產中70%的原料，並增加商業價值。根據Recovery Magazine報道，容器玻璃佔年產量1.3億噸的46%，全球回收率為32%。容器玻璃利用玻璃固有的永續性和材料特性，支持產業轉向採用永續實踐。

機會－日益關注可回收和生物分解性玻璃材料的開發

玻璃以其永續性和惰性特性而聞名，由於其能夠在不發生化學相互作用的情況下保持產品完整性，因此在藥品包裝中仍然很重要。硼矽酸玻璃和鈉鈣處理玻璃具有高水解性，適用於多種醫療製劑，包括水溶液和腸胃外藥物。玻璃配方和處理技術的進步不斷提高耐用性和環境相容性，符合環保解決方案的行業趨勢。隨著對永續包裝替代品的需求增加，可回收和生物分解性玻璃材料的創新有望維持和擴大藥品包裝市場的成長。

I型材質最常用於藥用玻璃包裝

全球藥用玻璃包裝市場由 I 型、II 型和 III 型材料組成。 I型玻璃材料，特別是硼矽酸玻璃，以其出色的耐化學反應性而聞名，非常適合儲存需要較強化學耐久性和穩定性的注射藥物、注射和製劑。其成分採用硼分子而不是鹼金屬氧化物，確保了化學惰性和良好的耐受性，使其成為包裝各種注射和精細治療的首選。因此，I類材料在全球藥用玻璃包裝市場中佔最大佔有率。

地緣政治緊張局勢加劇對全球藥用玻璃包裝市場的影響

不斷升級的地緣政治緊張局勢可能會對全球藥用玻璃包裝市場產生多方面的影響。地緣政治不穩定所造成的不確定性可能會危及生產所必需的原料的供應。貿易壁壘、關稅和政治不穩定都會增加成本並擾亂供應鏈，最終影響市場成長並迫使藥品包裝產業重新調整定價策略。這些挑戰造成了動盪的商業環境，阻礙了市場動態，並削弱了醫療保健行業的國內製造商和國際供應商的成長前景。

競爭格局

全球藥用玻璃包裝市場較為分散，大量企業進入該市場。主導全球藥用玻璃包裝市場的主要公司包括康寧公司、尼普羅、山東藥用玻璃有限公司、Bormioli Pharma SpA、Owens-Illinois, Inc.、SGD SA、Stoelzle Oberglas GmbH、Gerresheimer AG、West Pharmaceutical Services, Inc.、Piramal Enterprises Ltd、Arab Pharmaceutical Glass Co、Ardagh Group SA、Sisecam Group、Beatson Clark 和DWK Life sciences。每家公司採用​​的主要行銷策略是設施擴張、產品多元化、聯盟、合作、夥伴關係和收購，以擴大客戶範圍並獲得跨市場的競爭優勢。

該報告的詳細分析提供了有關全球藥用玻璃包裝市場的成長潛力、未來趨勢和統計數據的資訊。它還涵蓋了推動市場總規模預測的因素。該報告致力於提供全球藥用玻璃包裝市場的最新技術趨勢以及業界考察，以幫助決策者做出明智的戰略決策。此外，我們也分析了市場的成長動力、挑戰和競爭力。

目錄

第1章 研究框架

第 2 章執行摘要

第3章全球藥用玻璃包裝市場洞察

  • 產業價值鏈分析
  • DROC分析
    • 生長促進因子
      • 不斷成長的製藥業推動了包裝需求
      • 玻璃包裝卓越的安全性和可靠性
      • 擴大生技藥品市場有利於玻璃的兼容性
    • 抑制因素
      • 與塑膠替代品相比成本較高
      • 在運輸和裝卸過程中容易損壞
      • 與能源密集型生產相關的環境永續性議題
    • 機會
      • 輕質玻璃配方與處理技術的進步
      • 重點開發可回收或生物分解性的玻璃材料
      • 新興醫藥市場的擴張機會
    • 任務
      • 矽砂等原物料價格波動
      • 遵守嚴格的監管要求
      • 塑膠包裝技術進步帶來的競爭
  • 科技進步/最新趨勢
  • 法律規範
  • 波特五力分析

第4章全球藥用玻璃包裝市場：行銷策略

第5章全球藥用玻璃包裝市場概況

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按材質
      • Ⅰ型
      • II型
      • Ⅲ型
    • 依給藥途徑
      • 口服
      • 胃腸外的
      • 吸入
      • 其他（外用藥物）
    • 依產品
      • 管瓶
      • 瓶子
      • 藥筒和注射器
      • 安瓿
    • 依藥物類型
      • 非專利的
      • 品牌
      • 生物製藥
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲（中東/非洲）

第6章北美藥用玻璃包裝市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按材質
    • 依給藥途徑
    • 依產品
    • 依藥物類型
    • 按國家/地區
      • 美國
      • 加拿大

第7章歐洲藥用玻璃包裝市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按材質
    • 依給藥途徑
    • 依產品
    • 依藥物類型
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他歐洲國家

第8章亞太藥用玻璃包裝市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按材質
    • 依給藥途徑
    • 依產品
    • 依藥物類型
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲和紐西蘭
      • 印尼
      • 馬來西亞
      • 新加坡
      • 越南
      • 亞太地區其他國家

第9章 拉丁美洲藥用玻璃包裝市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按材質
    • 依給藥途徑
    • 依產品
    • 依藥物類型
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他拉丁美洲

第10章中東與非洲藥用玻璃包裝市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按材質
    • 依給藥途徑
    • 依產品
    • 依藥物類型
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • 中東和非洲其他地區

第11章競爭格局

  • 主要企業及其產品列表
  • 2023年全球藥用玻璃包裝市場佔有率分析
  • 透過管理參數進行競爭基準化分析
  • 重大策略發展（合併、收購、聯盟等）

第12章地緣政治緊張局勢升級對全球藥用玻璃包裝市場的影響

第13章 公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人員、主要競爭對手、聯絡方式、策略展望、SWOT分析）

  • Corning Incorporated
  • Nipro Corporation
  • Shandong Medicinal Glass Co., Ltd
  • Bormioli Pharma SpA
  • Owens-Illinois, Inc.
  • SGD SA
  • Stoelzle Oberglas GmbH
  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • Piramal Enterprises Ltd
  • Arab Pharmaceutical Glass Co.
  • Ardagh Group SA
  • Sisecam Group
  • Beatson Clark
  • DWK Life sciences
  • 其他主要企業

第14章 主要策略建議

第15章調查方法

簡介目錄
Product Code: BWC20292

Global Pharmaceutical Glass Packaging Market Size to Surpass Staggering Value of USD 30 Billion by 2030

Global Pharmaceutical Glass Packaging Market is flourishing because of a spurring demand for glass packaging from the thriving biopharmaceutical industry primarily due to its superior safety, reliability, and compatibility.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Pharmaceutical Glass Packaging Market size by value at USD 19.56 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Pharmaceutical Glass Packaging Market size to expand at a CAGR of 8.18% reaching a value of USD 30.03 billion by 2030. The Pharmaceutical Glass Packaging Market is propelled by the growing adoption of generic injectable drugs and substantial demand from the biopharmaceutical sector. Pharmaceutical glass, composed primarily of limestone, soda ash, cullet, and sand, incorporates essential elements like barium and zinc to enhance chemical resistance and durability. These properties are crucial for meeting stringent pharmaceutical standards, ensuring drug safety and packaging integrity. The industry's expansion is further fueled by increasing disease prevalence, driving the necessity for reliable glass packaging. The glass packaging shields medications from physical and biological harm while prolonging shelf life. With ongoing sector growth and technological advancements, the demand for pharmaceutical glass packaging is expected to surge during the period in analysis.

By volume, BlueWeave estimated Global Pharmaceutical Glass Packaging Market size at 6.82 million tons in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Pharmaceutical Glass Packaging Market size by volume is projected to grow at a CAGR of 8.42% reaching the volume of 9.11 million tons by 2030. Effective glass recycling plays a crucial role in meeting the growing demand for sustainable pharmaceutical packaging solutions. The Institute of Scrap Recycling Industries, Inc., highlights that recycled glass can replace 70% of raw materials in new production, enhancing its commodity value. Container glass constitutes 46% of the annual 130 million tons of glass produced, with a global recycling rate of 32%, as reported by Recovery Magazine. It supports the industry's shift toward adopting sustainable practices, leveraging glass's inherent sustainability and material properties.

Opportunity - Increasing focus on developing recyclable or biodegradable glass materials

Glass, renowned for its sustainability and inert properties, remains crucial in pharmaceutical packaging due to its ability to maintain product integrity without chemical interaction. Types such as borosilicate and treated soda-lime glass offer high hydrolytic resistance and suitability for various medical preparations, including aqueous solutions and parenteral medications. Advances in glass formulation and treatment technologies continue to improve durability and environmental compatibility, aligning with industry trends towards eco-friendly solutions. As the demand grows for sustainable packaging alternatives, innovations in recyclable and biodegradable glass materials promise to sustain and expand market growth in pharmaceutical packaging.

Type I Material Most Used in Pharmaceutical Glass Packaging

Global Pharmaceutical Glass Packaging Market comprises Type I, Type II, and Type III material segments. Type I glass material, particularly borosilicate glass, is renowned for its outstanding resistance to chemical reactions, making it highly suitable for preserving parenteral drugs, injectables, and formulations that demand robust chemical durability and stability. Its composition, incorporating boron molecules instead of alkaline oxides, ensures chemical inertness and superior resistance, making it the preferred option for packaging a diverse array of injectables and sensitive treatments. Hence, the type I material segment holds the largest share in Global Pharmaceutical Glass Packaging Market.

Impact of Escalating Geopolitical Tensions on Global Pharmaceutical Glass Packaging Market

Intensifying geopolitical tensions can have a multifaceted impact on Global Pharmaceutical Glass Packaging Market. Uncertainties stemming from geopolitical instability can jeopardize the availability of raw materials crucial for production. Trade barriers, tariffs, and political instability can all inflate costs and fracture supply chains, ultimately impacting market growth and forcing a recalibration of pricing strategies within the pharmaceutical packaging sector. These challenges converge to create a turbulent business environment, hindering market dynamics and dampening growth prospects for both domestic manufacturers and international suppliers operating within the healthcare sector.

Competitive Landscape

Global Pharmaceutical Glass Packaging Market is fragmented, with numerous players serving the market. The key players dominating Global Pharmaceutical Glass Packaging Market include Corning Incorporated, Nipro Corporation, Shandong Medicinal Glass Co., Ltd, Bormioli Pharma S.p.A., Owens-Illinois, Inc., SGD S.A., Stoelzle Oberglas GmbH, Gerresheimer AG, West Pharmaceutical Services, Inc., Piramal Enterprises Ltd, Arab Pharmaceutical Glass Co., Ardagh Group S.A., Sisecam Group, Beatson Clark, and DWK Life sciences. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and Global Pharmaceutical Glass Packaging Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Pharmaceutical Glass Packaging Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Pharmaceutical Glass Packaging Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Growing pharmaceutical industry driving demand for packaging
      • 3.2.1.2. Superior safety and reliability of glass packaging
      • 3.2.1.3. Increasing market for biologics favoring glass due to compatibility
    • 3.2.2. Restraints
      • 3.2.2.1. Higher cost compared to plastic alternatives
      • 3.2.2.2. Susceptibility to breakage during transportation and handling
      • 3.2.2.3. Environmental sustainability concerns related to energy-intensive production
    • 3.2.3. Opportunities
      • 3.2.3.1. Advancements in lightweight glass formulations and handling technologies
      • 3.2.3.2. Focus on developing recyclable or biodegradable glass materials
      • 3.2.3.3. Expansion opportunities in emerging pharmaceutical markets
    • 3.2.4. Challenges
      • 3.2.4.1. Volatility in raw material prices, such as silica sand
      • 3.2.4.2. Compliance with stringent regulatory requirements
      • 3.2.4.3. Competition from advancing plastic packaging technologies
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Pharmaceutical Glass Packaging Market: Marketing Strategies

5. Global Pharmaceutical Glass Packaging Market Overview

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share and Forecast
    • 5.2.1. By Material
      • 5.2.1.1. Type I
      • 5.2.1.2. Type II
      • 5.2.1.3. Type III
    • 5.2.2. By Route of Administration
      • 5.2.2.1. Oral
      • 5.2.2.2. Parenteral
      • 5.2.2.3. Inhalation
      • 5.2.2.4. Others (Topical etc.)
    • 5.2.3. By Product
      • 5.2.3.1. Vials
      • 5.2.3.2. Bottles
      • 5.2.3.3. Cartridges & Syringes
      • 5.2.3.4. Ampoules
    • 5.2.4. By Drug Type
      • 5.2.4.1. Generic
      • 5.2.4.2. Branded
      • 5.2.4.3. Biologics
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia Pacific (APAC)
      • 5.2.5.4. Latin America (LATAM)
      • 5.2.5.5. Middle East and Africa (MEA)

6. North America Pharmaceutical Glass Packaging Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Material
    • 6.2.2. By Route of Administration
    • 6.2.3. By Product
    • 6.2.4. By Drug Type
    • 6.2.5. By Country
      • 6.2.5.1. United States
      • 6.2.5.1.1. By Material
      • 6.2.5.1.2. By Route of Administration
      • 6.2.5.1.3. By Product
      • 6.2.5.1.4. By Drug Type
      • 6.2.5.2. Canada
      • 6.2.5.2.1. By Material
      • 6.2.5.2.2. By Route of Administration
      • 6.2.5.2.3. By Product
      • 6.2.5.2.4. By Drug Type

7. Europe Pharmaceutical Glass Packaging Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Material
    • 7.2.2. By Route of Administration
    • 7.2.3. By Product
    • 7.2.4. By Drug Type
    • 7.2.5. By Country
      • 7.2.5.1. Germany
      • 7.2.5.1.1. By Material
      • 7.2.5.1.2. By Route of Administration
      • 7.2.5.1.3. By Product
      • 7.2.5.1.4. By Drug Type
      • 7.2.5.2. United Kingdom
      • 7.2.5.2.1. By Material
      • 7.2.5.2.2. By Route of Administration
      • 7.2.5.2.3. By Product
      • 7.2.5.2.4. By Drug Type
      • 7.2.5.3. Italy
      • 7.2.5.3.1. By Material
      • 7.2.5.3.2. By Route of Administration
      • 7.2.5.3.3. By Product
      • 7.2.5.3.4. By Drug Type
      • 7.2.5.4. France
      • 7.2.5.4.1. By Material
      • 7.2.5.4.2. By Route of Administration
      • 7.2.5.4.3. By Product
      • 7.2.5.4.4. By Drug Type
      • 7.2.5.5. Spain
      • 7.2.5.5.1. By Material
      • 7.2.5.5.2. By Route of Administration
      • 7.2.5.5.3. By Product
      • 7.2.5.5.4. By Drug Type
      • 7.2.5.6. Belgium
      • 7.2.5.6.1. By Material
      • 7.2.5.6.2. By Route of Administration
      • 7.2.5.6.3. By Product
      • 7.2.5.6.4. By Drug Type
      • 7.2.5.7. Russia
      • 7.2.5.7.1. By Material
      • 7.2.5.7.2. By Route of Administration
      • 7.2.5.7.3. By Product
      • 7.2.5.7.4. By Drug Type
      • 7.2.5.8. The Netherlands
      • 7.2.5.8.1. By Material
      • 7.2.5.8.2. By Route of Administration
      • 7.2.5.8.3. By Product
      • 7.2.5.8.4. By Drug Type
      • 7.2.5.9. Rest of Europe
      • 7.2.5.9.1. By Material
      • 7.2.5.9.2. By Route of Administration
      • 7.2.5.9.3. By Product
      • 7.2.5.9.4. By Drug Type

8. Asia Pacific Pharmaceutical Glass Packaging Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Material
    • 8.2.2. By Route of Administration
    • 8.2.3. By Product
    • 8.2.4. By Drug Type
    • 8.2.5. By Country
      • 8.2.5.1. China
      • 8.2.5.1.1. By Material
      • 8.2.5.1.2. By Route of Administration
      • 8.2.5.1.3. By Product
      • 8.2.5.1.4. By Drug Type
      • 8.2.5.2. India
      • 8.2.5.2.1. By Material
      • 8.2.5.2.2. By Route of Administration
      • 8.2.5.2.3. By Product
      • 8.2.5.2.4. By Drug Type
      • 8.2.5.3. Japan
      • 8.2.5.3.1. By Material
      • 8.2.5.3.2. By Route of Administration
      • 8.2.5.3.3. By Product
      • 8.2.5.3.4. By Drug Type
      • 8.2.5.4. South Korea
      • 8.2.5.4.1. By Material
      • 8.2.5.4.2. By Route of Administration
      • 8.2.5.4.3. By Product
      • 8.2.5.4.4. By Drug Type
      • 8.2.5.5. Australia & New Zealand
      • 8.2.5.5.1. By Material
      • 8.2.5.5.2. By Route of Administration
      • 8.2.5.5.3. By Product
      • 8.2.5.5.4. By Drug Type
      • 8.2.5.6. Indonesia
      • 8.2.5.6.1. By Material
      • 8.2.5.6.2. By Route of Administration
      • 8.2.5.6.3. By Product
      • 8.2.5.6.4. By Drug Type
      • 8.2.5.7. Malaysia
      • 8.2.5.7.1. By Material
      • 8.2.5.7.2. By Route of Administration
      • 8.2.5.7.3. By Product
      • 8.2.5.7.4. By Drug Type
      • 8.2.5.8. Singapore
      • 8.2.5.8.1. By Material
      • 8.2.5.8.2. By Route of Administration
      • 8.2.5.8.3. By Product
      • 8.2.5.8.4. By Drug Type
      • 8.2.5.9. Vietnam
      • 8.2.5.9.1. By Material
      • 8.2.5.9.2. By Route of Administration
      • 8.2.5.9.3. By Product
      • 8.2.5.9.4. By Drug Type
      • 8.2.5.10. Rest of APAC
      • 8.2.5.10.1. By Material
      • 8.2.5.10.2. By Route of Administration
      • 8.2.5.10.3. By Product
      • 8.2.5.10.4. By Drug Type

9. Latin America Pharmaceutical Glass Packaging Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Material
    • 9.2.2. By Route of Administration
    • 9.2.3. By Product
    • 9.2.4. By Drug Type
    • 9.2.5. By Country
      • 9.2.5.1. Brazil
      • 9.2.5.1.1. By Material
      • 9.2.5.1.2. By Route of Administration
      • 9.2.5.1.3. By Product
      • 9.2.5.1.4. By Drug Type
      • 9.2.5.2. Mexico
      • 9.2.5.2.1. By Material
      • 9.2.5.2.2. By Route of Administration
      • 9.2.5.2.3. By Product
      • 9.2.5.2.4. By Drug Type
      • 9.2.5.3. Argentina
      • 9.2.5.3.1. By Material
      • 9.2.5.3.2. By Route of Administration
      • 9.2.5.3.3. By Product
      • 9.2.5.3.4. By Drug Type
      • 9.2.5.4. Peru
      • 9.2.5.4.1. By Material
      • 9.2.5.4.2. By Route of Administration
      • 9.2.5.4.3. By Product
      • 9.2.5.4.4. By Drug Type
      • 9.2.5.5. Rest of LATAM
      • 9.2.5.5.1. By Material
      • 9.2.5.5.2. By Route of Administration
      • 9.2.5.5.3. By Product
      • 9.2.5.5.4. By Drug Type

10. Middle East & Africa Pharmaceutical Glass Packaging Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Billion)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Material
    • 10.2.2. By Route of Administration
    • 10.2.3. By Product
    • 10.2.4. By Drug Type
    • 10.2.5. By Country
      • 10.2.5.1. Saudi Arabia
      • 10.2.5.1.1. By Material
      • 10.2.5.1.2. By Route of Administration
      • 10.2.5.1.3. By Product
      • 10.2.5.1.4. By Drug Type
      • 10.2.5.2. UAE
      • 10.2.5.2.1. By Material
      • 10.2.5.2.2. By Route of Administration
      • 10.2.5.2.3. By Product
      • 10.2.5.2.4. By Drug Type
      • 10.2.5.3. Qatar
      • 10.2.5.3.1. By Material
      • 10.2.5.3.2. By Route of Administration
      • 10.2.5.3.3. By Product
      • 10.2.5.3.4. By Drug Type
      • 10.2.5.4. Kuwait
      • 10.2.5.4.1. By Material
      • 10.2.5.4.2. By Route of Administration
      • 10.2.5.4.3. By Product
      • 10.2.5.4.4. By Drug Type
      • 10.2.5.5. South Africa
      • 10.2.5.5.1. By Material
      • 10.2.5.5.2. By Route of Administration
      • 10.2.5.5.3. By Product
      • 10.2.5.5.4. By Drug Type
      • 10.2.5.6. Nigeria
      • 10.2.5.6.1. By Material
      • 10.2.5.6.2. By Route of Administration
      • 10.2.5.6.3. By Product
      • 10.2.5.6.4. By Drug Type
      • 10.2.5.7. Algeria
      • 10.2.5.7.1. By Material
      • 10.2.5.7.2. By Route of Administration
      • 10.2.5.7.3. By Product
      • 10.2.5.7.4. By Drug Type
      • 10.2.5.8. Rest of MEA
      • 10.2.5.8.1. By Material
      • 10.2.5.8.2. By Route of Administration
      • 10.2.5.8.3. By Product
      • 10.2.5.8.4. By Drug Type

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Global Pharmaceutical Glass Packaging Market Share Analysis, 2023
  • 11.3. Competitive Benchmarking, By Operating Parameters
  • 11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Escalating Geopolitical Tensions on Global Pharmaceutical Glass Packaging Market

13. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 13.1. Corning Incorporated
  • 13.2. Nipro Corporation
  • 13.3. Shandong Medicinal Glass Co., Ltd
  • 13.4. Bormioli Pharma S.p.A.
  • 13.5. Owens-Illinois, Inc.
  • 13.6. SGD S.A.
  • 13.7. Stoelzle Oberglas GmbH
  • 13.8. Gerresheimer AG
  • 13.9. West Pharmaceutical Services, Inc.
  • 13.10. Piramal Enterprises Ltd
  • 13.11. Arab Pharmaceutical Glass Co.
  • 13.12. Ardagh Group S.A.
  • 13.13. Sisecam Group
  • 13.14. Beatson Clark
  • 13.15. DWK Life sciences
  • 13.16. Other Prominent Players

14. Key Strategic Recommendations

15. Research Methodology

  • 15.1. Qualitative Research
    • 15.1.1. Primary & Secondary Research
  • 15.2. Quantitative Research
  • 15.3. Market Breakdown & Data Triangulation
    • 15.3.1. Secondary Research
    • 15.3.2. Primary Research
  • 15.4. Breakdown of Primary Research Respondents, By Region
  • 15.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable